Vivos Therapeutics VVOS
NASDAQ VVOS
$0.13 -0.01 (-5.93%)
As of: Oct 20, 2026 · 11:41 AM EDT

Vivos Therapeutics (VVOS) Gross Margin (2020 - 2026)

Updated

Vivos Therapeutics' Gross Margin was 57.31% in Q2 2026, up 2.07 percentage points from 55.24% a year earlier but down 2.20 percentage points from the prior quarter.

Analysis

Vivos Therapeutics (VVOS) Gross Margin (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, Vivos Therapeutics' Gross Margin was 61.90% through Jun 30, 2026, up 5.97 percentage points year-over-year; for FY2025, it was 60.44%, up 0.43 percentage points from FY2024.

  • Gross Margin shows a five-year change of -19.26 percentage points (FY2020 to FY2025).
  • In earlier years, Gross Margin was 60.00% in FY2024 (+0.07 pp), 59.93% in FY2023 (-2.59 pp), 62.52% in FY2022 (-12.12 pp) and 74.65% in FY2021 (-5.05 pp).
  • Quarterly Gross Margin has moved between 50.03% (Q1 2025) and 78.14% (Q4 2025) over five years.
  • Compared with a year earlier, Gross Margin has increased for three straight quarters, with an average year-over-year change of +1.71 percentage points over the last eight quarters.
  • The best year-over-year quarter for Gross Margin over five years was Q4 2025 (a gain of 21.43 percentage points); the worst was Q2 2022 (a drop of 18.73 percentage points).
  • Per Business Quant data, VVOS's Gross Margin in the three quarters before Q2 2026 was 59.50% (Q1 2026), 78.14% (Q4 2025) and 58.04% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Thermo Fisher Scientific 253.95 Bn 232.98 Bn 4.88 Bn 40.70%
2 Abbott Laboratories 179.59 Bn 150.02 Bn 7.27 Bn 57.71%
3 Danaher 158.64 Bn 142.45 Bn 3.61 Bn 57.64%
4 Intuitive Surgical 154.10 Bn 133.52 Bn 1.96 Bn 67.78%
5 Medtronic 120.69 Bn 85.94 Bn 6.34 Bn 64.99%
6 Stryker 116.32 Bn 102.43 Bn 4.50 Bn 68.27%
7 Boston Scientific 67.41 Bn 62.18 Bn 3.85 Bn 70.71%
8 Becton Dickinson 53.03 Bn 50.18 Bn 2.32 Bn 46.46%
9 Edwards Lifesciences 50.87 Bn 34.88 Bn 1.35 Bn 77.46%
10 Vivos Therapeutics 2.24 Mn -6.80 Mn 2.95 Mn 57.31%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 57.31%
Mar 31, 2026 59.50%
Dec 31, 2025 78.14%
Sep 30, 2025 58.04%
Jun 30, 2025 55.24%
Mar 31, 2025 50.03%
Dec 31, 2024 56.71%
Sep 30, 2024 60.47%
Jun 30, 2024 65.39%
Mar 31, 2024 56.65%
Dec 31, 2023 64.32%
Sep 30, 2023 52.92%
Jun 30, 2023 61.80%
Mar 31, 2023 60.59%
Dec 31, 2022 60.35%
Sep 30, 2022 58.78%
Jun 30, 2022 61.85%
Mar 31, 2022 70.01%
Dec 31, 2021 70.71%
Sep 30, 2021 70.02%
API Access

Vivos Therapeutics Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=VVOS&period=max&api_key=YOUR_API_KEY